Switching from intravenous to subcutaneous infliximab biosimilar (Remsima®) in adult patients with inflammatory bowel disease: experience at an NHS trust
This supplement has been commissioned and funded by Celltrion Healthcare UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
CTHC-UK-219D (1) October 2020
High cost drugs in psoriasis: how to optimise patient care and budgets
This supplement has been commissioned and funded by Almirall Ltd and developed in partnership with Guidelines in Practice. Information intended for UK healthcare professionals only.
UK-NOP-2000055
An optimised patient pathway for the treatment of heterosexual patients with infertility
This supplement has been commissioned and funded by Merck Serono Ltd and developed in partnership with Guidelines in Practice.
Identification and management of patients with malnutrition
This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.
Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities
This supplement has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.
How should inhaled steroids be used in the management of asthma in adults within a primary care setting?
Information intended for healthcare professionals only.
Managing common skin conditions without antibiotics
This supplement has been commissioned and funded by Galderma and developed in partnership with Guidelines in Practice.
Guideline for the managed introduction of biosimilar basal insulin
This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.
